Sixteen months follow-up of health related quality of life in women with high-risk breast cancer after random assignment to adjuvant treatment with tailored dose-dense chemotherapy vs standard three-weekly adjuvant chemotherapy (PANTHER study). (February 2017) - Brandberg, Y.; Foukakis, T.; Johansson, H.; Hellström, M.; Gnant, M.; Loibl, S.; Bergh, J.